PCSK9 and COVID-19: A recent observational study found a significant increase in plasma PCSK9 levels in patients with COVID-19 sepsis compared to those without SARS-CoV-2 infection, suggesting that PCSK9 may be a potential biomarker for COVID-19 (103).